| Disease | EFFECT OF DECREASING MICROALBUMINURIA IN TYPE 2 DIABETES MELLITUS.
INDEXES WERE DECREASED TO (4+-21)%, (0.9+-10) MCG/L, (1+-66) NG/L, AND (1.4+-3.6) MG/MMOL, RESP.THERE WAS SIGNIFICAN DIFFERENCE BETWEEN THE TWO GROUPS (P<0.01). GINKGO BILOBA EXTRACT (GBE) IMPROVED THE FUNCTION OF PLATELET AND HAD THE
RATE WAS DECREASED BY (38+-15%). GMP-140,TXB2, AND URINAL ALB/CR WERE DECREASED SIGNIFICANTLY (P<0.01) TO (8+-16) MCG/L, (124+-88) NG/L, AND (8.1+-3.9) MG/MMOL, RESP. IN THE GBE GROUP, BUT IN THE CONVENTIONAL THERAPY GROUP, THE ABOVE
14 D. BEFORE AND AFTER TREATMENT, THE PLATELET AGGREGATION RATE, PLASMA ALPHA GRANULE MEMBRANE GLYCOPROTEIN-140 (GMP-140), THROMBOXANE B2 (TXB2) LEVEL,AND RATIO OF ALBUMIN TO CREATININE (ALB/CR) IN URINE WERE MEASURED. PLATELET AGGREGATION
WENT CONVENTIONAL TREATMENT OF TYPE 2 DM (GLICLAZIDE ALONE OR COMBINED WITH METFORMIN) WITH THE ADDN. OF GBE 70 MG + 0.9% SODIUM CHLORIDE 250 ML FOR 14 D. THE OTHER 26 AS CONTROL GROUP UNDERWENT SIMPLE CONVENTIONAL TREATMENT OF TYPE 2 DM FOR
THE EFFECT OF GINKGO BILOBA EXTRACT (GBE) ON THE PLATELET AGGREGATION AND MICROALBUMINURIA IN TYPE 2DIABETES MELLITUS (DM) WAS STUDIED. 52 PATIENTS WITH TYPE 2 DM COMPLICATED WITH MICROALBUMINURIA WERE DIVIDED INTO 2 GROUPS.26 PATIENTS UNDER |